"Agreement on the Need to Adopt mRNA Vaccine Technology"

[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Kim Ji-hee] The government announced that it is making efforts to secure vaccine technology to become a global vaccine hub country. In particular, it is focusing on messenger ribonucleic acid (mRNA) vaccine technology, which has recently gained popularity among COVID-19 vaccines such as Pfizer and Moderna.


Lee Ki-il, head of the intergovernmental vaccine introduction task force (TF) working support group, said at a public briefing on vaccines on the 26th, "Not only Pfizer, which was recently introduced, but also Moderna are mRNA vaccines, and we agree on the necessity of introducing mRNA vaccine technology," adding, "Currently, global pharmaceutical companies and our pharmaceutical companies are working on securing technology through research agreements."


He continued, "Most parties have a positive stance on technology transfer," and added, "If progress is made in the future, the government plans to actively cooperate and support."


mRNA vaccines are genetic vaccines that use messenger ribonucleic acid (mRNA) to induce an immune response against the COVID-19 virus. Unlike AstraZeneca or Janssen's viral vector vaccines, which were previously embroiled in blood clot controversies, mRNA vaccines do not use other vectors. So far, they have been reported to have fewer side effects and are considered relatively safe.



Meanwhile, before the Q&A session, Hong Nam-ki, Acting Prime Minister, stated in a public address, "We will develop our country into a global vaccine hub by developing domestic vaccines and expanding the domestic vaccine production base."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing